Grifols S.A. ADR (GRFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRFS | MDGL | CORT | ||
| Company | Grifols S.A. ADR | Madrigal Pharmaceuticals Inc | Corcept Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.44 | 318.42 | 56.16 | ||
| High | 8.59 | 329.93 | 57.24 | ||
| Low | 8.18 | 315.15 | 55.34 | ||
| Last | 8.54 | 329.24 | 55.92 | ||
| Change | -0.06 | +12.15 | -0.17 | ||
| % Change | -0.70% | +3.83% | -0.30% | ||
| Volume | 632,310 | 423,608 | 599,844 | ||
| 20-Day Average Volume | 1,157,600 | 670,525 | 1,129,367 | ||
| Previous Close | 8.60 | 317.09 | 56.09 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.95 | 300.11 | 52.82 | ||
| 20-Day Raw Stochastic | 23.24% | 76.35% | 70.78% | ||
| 20-Day Relative Strength | 45.80% | 64.76% | 62.47% | ||
| Weighted Alpha | +14.70 | +24.92 | +150.55 | ||
| Today's Opinion | 64% Buy | 72% Buy | 100% Buy | ||
| Previous Opinion | 64% Buy | 72% Buy | 100% Buy | ||
| Last Month's Opinion | 96% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.58% since 11/14/24 | +8.78% since 11/14/24 | +2.06% since 11/14/24 | ||
| Low | 8.18 on 11/21/24 | 272.72 on 11/15/24 | 51.51 on 11/15/24 | ||
| High | 9.69 on 11/15/24 | 329.93 on 11/21/24 | 57.24 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | -0.35% since 10/21/24 | +57.61% since 10/21/24 | +13.87% since 10/21/24 | ||
| Low | 8.11 on 10/29/24 | 200.63 on 10/23/24 | 42.01 on 10/31/24 | ||
| High | 9.96 on 11/08/24 | 368.29 on 11/07/24 | 61.66 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | +11.34% since 08/21/24 | +28.52% since 08/21/24 | +62.42% since 08/21/24 | ||
| Low | 7.13 on 09/25/24 | 200.63 on 10/23/24 | 33.34 on 09/04/24 | ||
| High | 9.96 on 11/08/24 | 368.29 on 11/07/24 | 61.66 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | +11.34% since 05/21/24 | +35.77% since 05/21/24 | +94.17% since 05/21/24 | ||
| Low | 5.79 on 06/27/24 | 200.63 on 10/23/24 | 27.30 on 05/24/24 | ||
| High | 9.96 on 11/08/24 | 368.29 on 11/07/24 | 61.66 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,913,016 | 6,915,730 | 5,876,830 | ||
| Shares Outstanding, K | 687,560 | 21,810 | 104,775 | ||
| Annual Sales | 7,134,500,000 | 0 | 482,380,000 | ||
| Annual Net Income | 64,200,000 | -373,630,000 | 106,140,000 | ||
| Last Quarter Sales | 1,971,530,000 | 62,180,000 | 182,550,000 | ||
| Last Quarter Net Income | 56,840,000 | -106,960,000 | 47,210,000 | ||
| 60-Month Beta | 0.50 | -0.46 | 0.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.02 on 07/30/24 | -4.92 on 10/31/24 | 0.41 on 10/30/24 | ||
| Latest Earnings Date | 08/01/24 | 10/31/24 | 10/30/24 | ||
| Most Recent Dividend | 0.370 on 06/03/21 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/03/21 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 43.10 | ||